Berkshire Hathaway: The Cash Is Real, the Question Is What It's Worth

Berkshire Hathaway released its second-quarter 2026 results today, reporting a 16% year-over-year jump in operating earnings and a cash-and-short-term-investments balance of $365.5 billion. Those are clean numbers on the surface. The less headline-friendly question is what they mean for the shareholder who holds BRK at 15.5 times trailing earnings, 1.54 times book value, and no dividend.

“ Operating earnings growth is the metric that matters most at Berkshire. It strips out investment gains and losses — the volatile mark-to-market swings from its massive equity portfolio — and focuses on what its owned businesses actually produced. A 16% increase from Q2 2025 to Q2 2026 is a strong quarter. It follows a Q1 2026 where operating earnings per Class B share came in at approximately $5.25. The trajectory is upward. ’” But growth in operating earnings doesn't automatically translate to compounding value at the current price. And that $365.5 billion cash pile — down slightly from the $397 billion recorded at the end of March, likely reflecting the Taylor Morrison acquisition, share repurchases, and ongoing capital deployment — isn't generating a return that shows up in operating earnings. It's sitting on the balance sheet as optionality, and optionality has a carrying cost. ’“ The ValuationGate`“ Berkshire trades at $1.125 trillion in market capitalization. That's an enormous number, but size alone isn't the objection. The valuation multiples tell the actual story. At 15.5 times trailing earnings, BRK.B sits roughly in line with JPMorgan Chase (14.9x) but ahead of Bank of America (13.8x) and Wells Fargo (12.2x). Berkshire isn't just a holding company that occasionally buys stocks — its insurance, railroad, energy, and manufacturing operations generate steady operating cash flow. Comparing it to large-cap financials is imperfect but useful for orientation. The point is that BRK isn't trading at a value discount to large financial peers. At 1.54 times book value, it's below JPMorgan's 2.54x but above BAC's 1.47x and WFC's 1.45x. The stock trades at a slight book-value premium to where most large banks are priced. ’“ Revenue growth for the trailing twelve months is 0.8%, essentially flat. Free cash flow, however, surged 97.9% year-over-year to $23.9 billion, with FCF margin at 5.7%. That FCF surge is largely driven by normalization after a rough 2024 period rather than structural acceleration. Return on invested capital came in negative at -2.1%, while return on equity was 10.5%. The ROIC figure is distorted by Berkshire's enormous investment portfolio sitting on the balance sheet, which can drag the ratio when equity holdings underperform. ROE at 10.5% is serviceable but not exceptional for a compounder being asked to justify its valuation. ’"‘theEarningsEstimatePicture³“ The earnings estimate picture shows what the market expects going forward. Consensus for Q3 2025 was $5.72 per Class B share; actual came in at $6.26. Q4 consensus was $5.51; actual was $4.73. The pattern is volatility. For Q2 2026, consensus was approximately $5.04. Actual EPS came in at $5.17. A modest beat, but nothing that reshapes the valuation case on its own. ''" the$365.5BillionProblem'' heBalanceSheetGate’“ Berkshire's balance sheet carries $522.8 billion in total debt against $729.5 billion in total equity, for a debt-to-equity ratio of 17.7%. That's conservative. The Taylor Morrison acquisition (~$6.8 billion) and ongoing buyback program consume cash, but leverage stays manageable. The issue isn't that Berkshire is sitting on cash. The issue is what that cash earns versus what shareholders could earn deploying the capital themselves. ''